Zachary L. Bernstein

Zachary L. Bernstein

Auto-generated profile, based on publicly available information

Zachary L. Bernstein

Department of Neurosurgery, Emory University School of Medicine, 1365 Clifton Road NE, Atlanta, GA 30322, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2022 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
AVAlexander J. Vervaecke
Alexander J. Vervaecke
ACAndrew D. Carbone
Andrew D. Carbone
AAAdam Abraham
Adam Abraham
ZBZachary Bernstein
Zachary Bernstein
DLDamien Laudier
Damien Laudier
AHAlice H. Huang
Alice H. Huang

21 July 2023 in Surgical Neurology International
Verified
Journal Article
Open access
ZBZachary Bernstein
Zachary Bernstein
DADavid Cory Adamson
David Cory Adamson
Hepatocellular carcinoma (HCC) is a common malignant tumor with a 5-year survival rate of 10%, presenting with extrahepatic metastases in 15-17% of patients. HCC-bone metastases represent approximately one-quarter of all HCC metastases, most frequently in the spine, pelvis, ribs, or femur. HCC-skull metastases, however, make up 0.4-1.6% of all HCC- bone metastases. Furthermore, solitary HCC-skull metastasis without known active primary HCC is an unusual presentation warranting further review and consideration. Here, the authors report a unique case of a solitary HCC-skull metastasis in a patient without known active cancer but in long-term remission for HCC. The patient is a 69-year-old male with past HCC who presented with a nontender skull mass. A computed tomography scan showed a heterogeneously enhancing mass centered in the high left parietal bone with intracranial extension. There was a noted mass effect on the left posterior frontoparietal region without worrisome midline shift. Pathology ultimately revealed the mass to be metastatic HCC. To aid in the understanding and clinical management of this rare presentation, we reviewed the literature regarding clinical presentation, radiological features, pathology, and outcome. Ultimately, early detection of the primary source of cancer is pivotal to successful treatment and prognosis, and skull lesions such as these must include HCC in the differential diagnosis.

7 April 2025 in Epilepsy & Behavior
Verified
Journal Article
Closed access
ZBZachary L Bernstein
Zachary L Bernstein
ARAshley Lb Raghu
Ashley Lb Raghu
AZAmir P Divanbeighi Zand
Amir P Divanbeighi Zand
AKAmmar Kheder
Ammar Kheder
RGRobert E Gross
Robert E Gross

7 February 2024 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
ZBZachary Bernstein
Zachary Bernstein
ZCZvipo M Chisango
Zvipo M Chisango
SMSai Mannam
Sai Mannam
DBDavid Bray
David Bray
KHKimberly Hoang
Kimberly Hoang

21 July 2025 in Neurosurgery
Verified
Journal Article
Closed access
ZBZachary L. Bernstein
Zachary L. Bernstein
ASAlexander J. Schupper
Alexander J. Schupper

1 September 2022 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
ZBZachary L. Bernstein
Zachary L. Bernstein
JKJoshua D. Kirschenbaum
Joshua D. Kirschenbaum
MGMatthew J. Gluck
Matthew J. Gluck
MHMichael R. Hausman
Michael R. Hausman